Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales.
To achieve commercial success, in vitro diagnostic (IVD) companies must earn the approval of several different groups. Regulators, payer organizations, healthcare providers and laboratory technicians ultimately determine the value of a product -- and how well it will do in the market. For that reason, strategic market-focused product development and effective commercialization are crucial.
Companies Included in Report
Aqueous Biomedical
Athena Diagnostics
BioVeritas
GeneExcel
Charts and Graphics
The list below reveals the key metrics included in In Vitro Diagnostics:
Chapter 1: Trends in IVD Product Investment
• Total Investment and Development Time
• Marketing Investment and Development Time
• Projected Market Life
Chapter 2: Diagnostic Product Development
• R&D and Manufacturing Costs by Timeframe
• Average R&D and Manufacturing Costs by Timeframe
Chapter 3: Diagnostic Marketing and Commercialization
• Introducing the Commercial Team
• Marketing Investments by Timeframe: Investments Under $1 Million
• Marketing Investments by Timeframe: Investments of $1 Million or Greater
Development and Commercialization Resources
• Product Budget: Budget levels for marketing and R&D and manufacturing from early development through the second year on the market
• Product Staffing: Staffing headcounts throughout development and the first year on the market
Duration of Development Stages
It is impossible to present a standard benchmark for the amount of time it takes to develop diagnostics products. While the evolution of some products takes more than 10 years, other IVDs fly through development and hit the market in less than three years.
for more information, please visit our web site :
http://www.bharatbook.com/
